Literature DB >> 15868359

[Cardiac manifestations of muscular dystrophies].

A Perrot1, S Spuler, C Geier, R Dietz, K J Osterziel.   

Abstract

Muscular dystrophies (MD) are a clinically and genetically heterogeneous disease group. In the last few years, remarkable progress has been made in understanding the close und various relations between skeletal muscle disease and heart muscle disease. Cardiac involvement has been documented in a number of primary MDs and is even the dominant feature in some of them. The myocardium can be affected in the form of a dilated cardiomyopathy while the conduction system can be affected resulting in arrhythmias and conduction defects. Many patients with MD die because of cardiac complications like sudden cardiac death or congestive heart failure. Detailed clinical data about cardiac involvement are available for Duchenne/Becker MD, Emery-Dreifuss MD, myotonic dystrophy, and the different limb girdle MDs. Cardiac manifestations were also found in congenital MD, central core disease, proximal myotonic myopathy, and nemaline myopathy. No data about cardiac abnormalities are available in oculopharyngeal MD and rippling muscle disease. The heart of patients with primary MD should be carefully investigated because of the life-threatening events caused by cardiac complications. There is a strong need for a close collaboration between neurologists and cardiologists in order to provide optimal disease management for the affected patients.

Entities:  

Mesh:

Year:  2005        PMID: 15868359     DOI: 10.1007/s00392-005-0232-3

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  38 in total

1.  Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series.

Authors:  A E Buckley; J Dean; I R Mahy
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

2.  [Guidelines for the treatment of chronic heart failure. Issued by the Executive Committee of the German Society of Cardiology--Heart and Circulation Research, compiled on behalf of the Commission of Clinical Cardiology in cooperation with Pharmaceutic Commission of the German Physicians' Association].

Authors:  U C Hoppe; E Erdmann
Journal:  Z Kardiol       Date:  2001-03

3.  Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.

Authors:  R C Betz; B G Schoser; D Kasper; K Ricker; A Ramírez; V Stein; T Torbergsen; Y A Lee; M M Nöthen; T F Wienker; J P Malin; P Propping; A Reis; W Mortier; T J Jentsch; M Vorgerd; C Kubisch
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

Review 4.  The Fukuyama congenital muscular dystrophy story.

Authors:  T Toda; K Kobayashi; E Kondo-Iida; J Sasaki; Y Nakamura
Journal:  Neuromuscul Disord       Date:  2000-03       Impact factor: 4.296

5.  Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy.

Authors:  A Lazarus; J Varin; Z Ounnoughene; H Radvanyi; C Junien; J Coste; P Laforet; B Eymard; H M Becane; S Weber; D Duboc
Journal:  Circulation       Date:  1999-03-02       Impact factor: 29.690

6.  Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.

Authors:  M C Dalakas; K Y Park; C Semino-Mora; H S Lee; K Sivakumar; L G Goldfarb
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

7.  Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy.

Authors:  E M Hoogerwaard; P A van der Wouw; A A Wilde; E Bakker; P F Ippel; J C Oosterwijk; D F Majoor-Krakauer; A J van Essen; N J Leschot; M de Visser
Journal:  Neuromuscul Disord       Date:  1999-07       Impact factor: 4.296

8.  Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects.

Authors:  R Anan; M Nakagawa; M Miyata; I Higuchi; S Nakao; M Suehara; M Osame; H Tanaka
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

9.  Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.

Authors:  L Politano; V Nigro; L Passamano; V Petretta; L I Comi; S Papparella; G Nigro; P F Rambaldi; P Raia; A Pini; M Mora; M A Giugliano; M G Esposito; G Nigro
Journal:  Neuromuscul Disord       Date:  2001-03       Impact factor: 4.296

10.  Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy.

Authors:  Giovanni Corrado; Alberto Lissoni; Sandro Beretta; Laura Terenghi; Giorgio Tadeo; Giovanni Foglia-Manzillo; Luca M Tagliagambe; Manuela Spata; Mauro Santarone
Journal:  Am J Cardiol       Date:  2002-04-01       Impact factor: 2.778

View more
  1 in total

1.  The heart in muscular dystrophies.

Authors:  J Finsterer; Claudia Stöllberger
Journal:  Z Kardiol       Date:  2005-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.